Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Hussein Baharlooi"'
Publikováno v:
Advanced Pharmaceutical Bulletin, Vol 12, Iss 2, Pp 389-397 (2022)
Purpose: Promising advances have been made in mesenchymal stem cell transplantation to reinducethe immune tolerance in neuroinflammatory animal models and multiple sclerosis (MS)patients. The available evidence demonstrated that immunomodulatory effe
Externí odkaz:
https://doaj.org/article/4345ac4e8df94cd493010477cfeb531a
Autor:
Mehrdad Gholamzad, Hussein Baharlooi, Mehdi Shafiee Ardestani, Zeinab Seyedkhan, Maryam Azimi
Publikováno v:
Advanced Pharmaceutical Bulletin, Vol 11, Iss 3, Pp 505-513 (2021)
Purpose: Multiple sclerosis (MS) is a debilitating neuroinflammatory disorder of the central nervous system. It is believed to result from an impaired immune response against myelin components especially myelin oligodendrocyte glycoprotein (MOG). Som
Externí odkaz:
https://doaj.org/article/06ce98cfba274e44a5e716c56d4101b3
Publikováno v:
Acta Medica Iranica, Vol 56, Iss 7 (2018)
No Abstract
Externí odkaz:
https://doaj.org/article/d96aa19ebbfb4379b7f3dd62f0babb22
Autor:
Habib Yarizadeh, Bahar Hassani, Saeed Nosratabadi, Hussein Baharlooi, Sara Asadi, Seyed Ahmad Bagherian, Shariful Islam, Kurosh Djafarian, Khadijeh Mirzaei
Publikováno v:
Evidence-Based Complementary and Alternative Medicine, Vol 2021 (2021)
Evidence-based Complementary and Alternative Medicine : eCAM
Evidence-based Complementary and Alternative Medicine : eCAM
Background. It is uncertain if omega-3 polyunsaturated fatty acids are associated with increase in resting metabolic rate (RMR) in adults. Objective. The aim of the present study was to evaluate the overall effects of omega-3 on RMR. Methods. Both Pu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ae64054c67b9bfa12616c248bb7f35a
https://doi.org/10.1155/2021/6213035
https://doi.org/10.1155/2021/6213035
Autor:
Maryam Azimi, Hussein Baharlooi, Leila Mohamed Khosroshahi, Moein Minbashi Moeini, Amir Hossein Mansourabadi
Publikováno v:
Cellular and Molecular Neurobiology. 42:2611-2627
The issue of treating Multiple Sclerosis (MS) begins with disease-modifying treatments (DMTs) which may cause lymphopenia, dyspnea, and many other adverse effects. Consequently, further identification and evaluation of alternative treatments are cruc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c204d6dc836e872c0318b9696af3391a
https://doi.org/10.1007/s10571-021-01158-4
https://doi.org/10.1007/s10571-021-01158-4
Publikováno v:
International Journal of Stem Cells
With the development of novel treatments for autoimmune disorders, it has become a popular research focus which mesenchymal stem cells (MSCs) have the capacity to counteract with autoimmune diseases progression. One of the underlying mechanisms behin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e1c6a5f95beb24c3c32d8f3da3dd4c0
https://doi.org/10.15283/ijsc19108
https://doi.org/10.15283/ijsc19108
Autor:
Hussein, Baharlooi, Amir Hossein, Mansourabadi, Moein, Minbashi Moeini, Leila, Mohamed Khosroshahi, Maryam, Azimi
Publikováno v:
Cellular and molecular neurobiology. 42(8)
The issue of treating Multiple Sclerosis (MS) begins with disease-modifying treatments (DMTs) which may cause lymphopenia, dyspnea, and many other adverse effects. Consequently, further identification and evaluation of alternative treatments are cruc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e9a1c220539bd99320083a383eec4076
https://pubmed.ncbi.nlm.nih.gov/34694513
https://pubmed.ncbi.nlm.nih.gov/34694513
Autor:
Maryam Azimi, Zeynab Nouraei, Maryam Izad, Batool Moradi, Mohammad Javad Tavassolifar, Mohammad Ali Sahraian, Abdorreza Naser Moghadasi, Hussein Baharlooi
Publikováno v:
Scandinavian Journal of Immunology.
Multiple sclerosis (MS) is a central nervous system (CNS) degenerative disorder which is caused by a targeted autoimmune-mediated attack on myelin proteins. Previously, mesenchymal stem cells were considered as a novel and successful treatment of MS.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e85b8706167f1d7b0af759a04f3ce448
https://doi.org/10.1111/sji.13013
https://doi.org/10.1111/sji.13013
Publikováno v:
Advanced pharmaceutical bulletin. 12(2)
Purpose: Promising advances have been made in mesenchymal stem cell transplantation to re-induce the immune tolerance in neuroinflammatory animal models and Multiple Sclerosis patients. The available evidence demonstrated that immunomodulatory effect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64e552975f504333e3f42e6320608cd6
https://pubmed.ncbi.nlm.nih.gov/35620339
https://pubmed.ncbi.nlm.nih.gov/35620339
Autor:
Hussein Baharlooi, Mehrdad Gholamzad, Maryam Azimi, Zeinab Seyedkhan, Mehdi Shafiee Ardestani
Publikováno v:
Advanced Pharmaceutical Bulletin, Vol 11, Iss 3, Pp 505-513 (2021)
Advanced Pharmaceutical Bulletin
Advanced Pharmaceutical Bulletin
Purpose: Multiple sclerosis (MS) is a debilitating neuroinflammatory disorder of the central nervous system. It is believed to result from an impaired immune response against myelin components especially myelin oligodendrocyte glycoprotein (MOG). Som
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8392a13635d770efc4c8a01521083964
https://doi.org/10.34172/apb.2021.058
https://doi.org/10.34172/apb.2021.058